{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:29:48Z","timestamp":1783463388260,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s00108-007-1807-z","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T10:41:41Z","timestamp":1171449701000},"page":"246-254","source":"Crossref","is-referenced-by-count":4,"title":["Das Herz bei endokrinen Erkrankungen","Endocrine disorders and the heart"],"prefix":"10.1007","volume":"48","author":[{"given":"Onno E.","family":"Jan\u00dfen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Erbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1807_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.0.CO;2-Q","volume":"15","author":"Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) New diagnostic criteria and classification of diabetes \u2013 again? Diabet Med 15: 535\u2013536","journal-title":"Diabet Med"},{"key":"1807_CR2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1067\/mhj.2002.123572","volume":"144","author":"Bruch","year":"2002","unstructured":"Bruch C, Herrmann B, Schmermund A et al. (2002) Impact of disease activity on left ventricular performance in patients with acromegaly. Am Heart J 144: 538\u2013543","journal-title":"Am Heart J"},{"key":"1807_CR3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2265.2004.02156.x","volume":"61","author":"Dagres","year":"2004","unstructured":"Dagres N, Saller B, Haude M et al. (2004) Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol 61: 724\u2013731","journal-title":"Clin Endocrinol"},{"key":"1807_CR4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","volume":"22","author":"Marco","year":"1999","unstructured":"Marco R de, Locatelli F, Zoppini G et al. (1999) Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22: 756\u2013761","journal-title":"Diabetes Care"},{"key":"1807_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383\u2013393","journal-title":"N Engl J Med"},{"key":"1807_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T et al. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229\u2013234","journal-title":"N Engl J Med"},{"key":"1807_CR7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-2005-870236","volume":"37","author":"Hahn","year":"2005","unstructured":"Hahn S, Tan S, Elsenbruch S et al. (2005) Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 37: 438\u2013444","journal-title":"Horm Metab Res"},{"key":"1807_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132: 270\u2013278","journal-title":"Ann Intern Med"},{"key":"1807_CR9","first-page":"1","volume":"Invest","author":"Hanefeld","year":"2000","unstructured":"Hanefeld M (2000) Postprandial state abnormalities: neglected cardiovascular risk factors in diabetes. Introduction. Eur J Clin Invest (Suppl 2) 30: 1\u20132","journal-title":"Eur J Clin"},{"key":"1807_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2002.01528.x","volume":"56","author":"Herrmann","year":"2002","unstructured":"Herrmann BL, Bruch C, Saller B et al. (2002) Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy. Clin Endocrinol 56: 595\u2013602","journal-title":"Clin Endocrinol"},{"key":"1807_CR11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00059-004-2563-7","volume":"29","author":"Herrmann","year":"2004","unstructured":"Herrmann BL, Erbel R, Janssen OE et al. (2004) Kardiovaskulare Effekte oraler Antidiabetika. Herz 29: 510\u2013518","journal-title":"Herz"},{"key":"1807_CR12","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2003-031089","volume":"89","author":"Imaizumi","year":"2004","unstructured":"Imaizumi M, Akahoshi M, Ichimaru S et al. (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89: 3365\u20133370","journal-title":"J Clin Endocrinol Metab"},{"key":"1807_CR13","first-page":"41","volume":"22","author":"Johannsson","year":"1999","unstructured":"Johannsson G, Bengtsson BA (1999) Growth hormone and the metabolic syndrome. J Endocrinol Invest 22: 41\u201346","journal-title":"J Endocrinol Invest"},{"key":"1807_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2004.09.021","volume":"179","author":"Kelemen","year":"2005","unstructured":"Kelemen M, Vaidya D, Waters DD et al. (2005) Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women\u2019s Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis 179: 193\u2013200","journal-title":"Atherosclerosis"},{"key":"1807_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393\u2013403","journal-title":"N Engl J Med"},{"key":"1807_CR16","unstructured":"Lehnert H (2003) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart"},{"key":"1807_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000095530","volume":"83","author":"Lombardi","year":"2006","unstructured":"Lombardi G, Galdiero M, Auriemma RS et al. (2006) Acromegaly and the cardiovascular system. Neuroendocrinology 83: 211\u2013217","journal-title":"Neuroendocrinology"},{"key":"1807_CR18","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355: 2558\u20132573","journal-title":"N Engl J Med"},{"key":"1807_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwj079","volume":"163","author":"Prentice","year":"2006","unstructured":"Prentice RL, Langer RD, Stefanick ML et al. (2006) Combined analysis of Women\u2019s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol 163: 589\u2013599","journal-title":"Am J Epidemiol"},{"key":"1807_CR20","first-page":"982","volume":"367","author":"PROactive","year":"2006","unstructured":"PROactive Study Executive Committee and Data and Safety Monitoring Committee (2006) PROactive study. Lancet 367: 982","journal-title":"Lancet"},{"key":"1807_CR21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.0000019884.36724.D9","volume":"106","author":"Reaven","year":"2002","unstructured":"Reaven G (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106: 286\u2013288","journal-title":"Circulation"},{"key":"1807_CR22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1210\/jc.2005-0981","volume":"91","author":"Salerno","year":"2006","unstructured":"Salerno M, Esposito V, Farina V et al. (2006) Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study. J Clin Endocrinol Metab 91: 1288\u20131295","journal-title":"J Clin Endocrinol Metab"},{"key":"1807_CR23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1055\/s-2008-1055469","volume":"120","author":"Schmermund","year":"1995","unstructured":"Schmermund A, Lange S, Sehnert C et al. (1995) Electron beam tomography in coronary disease. Prevalence and distribution of coronary calcifications and their relationship with coronary risk factors in 650 patients. Dtsch Med Wochenschr 120: 1229\u20131235","journal-title":"Dtsch Med Wochenschr"},{"key":"1807_CR24","unstructured":"Seely EW, Williams GH (2001) The cardiovascular system and endocrine disease. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins, Philadelphia, pp 1857\u20131864"},{"key":"1807_CR25","first-page":"211","volume":"47","author":"Tan","year":"2005","unstructured":"Tan S, Hahn S, Janssen OE (2005) Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Panminerva Med 47: 211\u2013217","journal-title":"Panminerva Med"},{"key":"1807_CR26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2001-11317","volume":"126","author":"Temelkova-Kurktschiev","year":"2001","unstructured":"Temelkova-Kurktschiev T, Fischer S, Koehler C et al. (2001) [Intima-media thickness in healthy probands without risk factors for arteriosclerosis]. Dtsch Med Wochenschr 126: 193\u2013197","journal-title":"Dtsch Med Wochenschr"},{"key":"1807_CR27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854\u2013865","journal-title":"Lancet"},{"key":"1807_CR28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837\u2013853","journal-title":"Lancet"},{"key":"1807_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2005.02.033","volume":"107","author":"Zeymer","year":"2006","unstructured":"Zeymer U (2006) Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes. Int J Cardiol 107: 11\u201320","journal-title":"Int J Cardiol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1807-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1807-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1807-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:40Z","timestamp":1558584700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1807-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1807-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}